1043270

GlaxoSmithKline LLC — FEI 1033964

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 26, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Zebulon, NC (United States)